Combretastatin A-4 prodrug inhibits growth of human non–small cell lung cancer in a murine xenotransplant model
- 1 May 2001
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 71 (5) , 1657-1665
- https://doi.org/10.1016/s0003-4975(01)02408-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The international system for staging lung cancerSeminars in Surgical Oncology, 2000
- Endostatin Induces Endothelial Cell ApoptosisJournal of Biological Chemistry, 1999
- Positron emission tomography of murine liver metastases and the effects of treatment by combretastatin A-4.European Journal of Nuclear Medicine and Molecular Imaging, 1999
- The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: effects on radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Novel Combretastatin Analogues Effective against Murine Solid Tumors: Design and Structure−Activity RelationshipsJournal of Medicinal Chemistry, 1998
- Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic statusBritish Journal of Cancer, 1998
- Clinical Applications of Research on AngiogenesisNew England Journal of Medicine, 1995
- The interaction with tubulin of a series of stilbenes based on combretastatin A-4British Journal of Cancer, 1995
- Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4Cellular and Molecular Life Sciences, 1989